According to FutureWise analysis the market for Lateral Flow Assays in 2023 was US$ 9.59 billion, and is expected to reach US$ 14.08 billion by 2031 at a CAGR of 4.92%. Lateral flow refers to a kind of immunoassay that employs a paper-based strip to identify the presence of a specific target analyte, such as a virus or a protein biomarker, within a biological sample. A sample is...